Ventria Bioscience: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Line 1: Line 1:
'''Ventria Bioscience''' is a [[biotechnology]] company that specializes in the development and commercialization of plant-made pharmaceuticals. The company was founded in 1993 and is headquartered in [[Sacramento]], [[California]], United States.
{{short description|American biotechnology company}}
{{Use mdy dates|date=October 2023}}


== History ==
[[File:Ventria-logo.PNG|thumb|right|Logo of Ventria Bioscience]]
Ventria Bioscience was established in 1993 with the aim of developing and commercializing plant-made pharmaceuticals. The company's initial focus was on the production of [[recombinant proteins]] in plants, a process known as [[molecular farming]] or [[pharming (genetics)|pharming]].


== Technology ==
'''Ventria Bioscience''' is an American [[biotechnology]] company that specializes in the development and commercialization of [[recombinant proteins]] derived from [[plant-based expression systems]]. The company is known for its innovative use of [[genetically modified organisms]] to produce proteins for use in [[pharmaceuticals]], [[nutraceuticals]], and other applications.
Ventria Bioscience utilizes a proprietary technology platform known as ExpressTec. This technology enables the production of recombinant proteins in the seeds of [[rice]] plants. The proteins can then be extracted and purified for use in pharmaceutical applications. ExpressTec has been used to produce a variety of proteins, including [[lactoferrin]], [[lysozyme]], and [[human serum albumin]].


== Products ==
==History==
Ventria Bioscience has developed several products using its ExpressTec technology. These include a rehydration solution called InVitria, which contains recombinant human lactoferrin and lysozyme. The company has also developed a line of skincare products under the brand name Vantria, which contain recombinant human lactoferrin.
Ventria Bioscience was founded in 1993 and is headquartered in [[Fort Collins, Colorado]]. The company initially focused on developing plant-based systems for producing [[therapeutic proteins]]. Over the years, Ventria has expanded its technology platform and product offerings, establishing itself as a leader in the field of plant-made pharmaceuticals.


== Controversies ==
==Technology==
Ventria Bioscience has faced controversy over its use of genetically modified rice plants to produce pharmaceuticals. Critics argue that this could lead to the contamination of the food supply, while the company maintains that it has implemented strict controls to prevent such contamination.
Ventria Bioscience utilizes a proprietary technology known as [[ExpressTec]], which involves the use of [[genetically engineered]] [[rice]] plants to produce recombinant proteins. This method offers several advantages over traditional protein production systems, including lower costs, scalability, and reduced risk of contamination with human pathogens.


== See also ==
==Products==
* [[Biopharming]]
The company's product portfolio includes a range of recombinant proteins used in various industries. Notable products include:
* [[Genetically modified crops]]
 
* '''LactoFerrin''': A protein with applications in [[infant formula]] and [[dietary supplements]].
* '''Lysozyme''': An enzyme used in [[food preservation]] and [[pharmaceuticals]].
* '''Human Serum Albumin''': Used in [[cell culture]] media and [[therapeutic]] applications.
 
==Controversies==
Ventria Bioscience has faced criticism and regulatory challenges related to the use of genetically modified crops. Concerns have been raised about the potential environmental impact and the safety of consuming products derived from genetically modified organisms. The company has worked to address these concerns through rigorous testing and compliance with regulatory standards.
 
==Related pages==
* [[Biotechnology]]
* [[Genetically modified organism]]
* [[Recombinant DNA]]
* [[Recombinant DNA]]


== References ==
==References==
<references />
{{reflist}}


[[Category:Biotechnology companies of the United States]]
[[Category:Biotechnology companies of the United States]]
[[Category:Companies based in Sacramento, California]]
[[Category:Companies based in Fort Collins, Colorado]]
[[Category:Pharmaceutical companies of the United States]]
[[Category:Genetic engineering and agriculture]]
{{Biotech-stub}}

Revision as of 11:57, 9 February 2025

American biotechnology company



File:Ventria-logo.PNG
Logo of Ventria Bioscience

Ventria Bioscience is an American biotechnology company that specializes in the development and commercialization of recombinant proteins derived from plant-based expression systems. The company is known for its innovative use of genetically modified organisms to produce proteins for use in pharmaceuticals, nutraceuticals, and other applications.

History

Ventria Bioscience was founded in 1993 and is headquartered in Fort Collins, Colorado. The company initially focused on developing plant-based systems for producing therapeutic proteins. Over the years, Ventria has expanded its technology platform and product offerings, establishing itself as a leader in the field of plant-made pharmaceuticals.

Technology

Ventria Bioscience utilizes a proprietary technology known as ExpressTec, which involves the use of genetically engineered rice plants to produce recombinant proteins. This method offers several advantages over traditional protein production systems, including lower costs, scalability, and reduced risk of contamination with human pathogens.

Products

The company's product portfolio includes a range of recombinant proteins used in various industries. Notable products include:

Controversies

Ventria Bioscience has faced criticism and regulatory challenges related to the use of genetically modified crops. Concerns have been raised about the potential environmental impact and the safety of consuming products derived from genetically modified organisms. The company has worked to address these concerns through rigorous testing and compliance with regulatory standards.

Related pages

References

<references group="" responsive="1"></references>